Physician profile
Stuart A Chasan
NPI 1457351496
$1,286.66
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $101 · 2021: $328 · 2022: $273.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $299.04 | 2019-2022 | |
| Urovant Sciences INC | $175.23 | 2021-2022 | |
| Allergan, INC. | $156.54 | 2019-2021 | |
| Boston Scientific Corporation | $96.78 | 2019-2021 | |
| Medtronic, INC. | $83.83 | 2022 | |
| Ferring Pharmaceuticals INC. | $65.94 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $60.66 | 2021-2022 | |
| 180 Medical, INC. | $37.93 | 2021 | |
| Janssen Biotech, INC. | $34.32 | 2019 | |
| Myovant Sciences INC. | $33.37 | 2022 | |
| Dendreon Pharmaceuticals LLC | $32.92 | 2021 | |
| Pfizer INC. | $29.95 | 2019 | |
| Myriad Genetic Laboratories, INC. | $26.92 | 2021 | |
| Amgen INC. | $22.59 | 2019 | |
| Sun Pharmaceutical Industries INC. | $22.13 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $17.26 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.22 | 2021 | |
| Rochester Medical Corporation | $14.21 | 2019 | |
| Abbvie INC. | $13.50 | 2021 | |
| Endo Pharmaceuticals INC. | $12.90 | 2019 | |
| Neotract INC. | $12.08 | 2020 | |
| Medtronic USA, INC. | $11.55 | 2020 | |
| Zyla Life Sciences, INC. | $10.79 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Chasan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.